The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.50
Bid: 170.00
Ask: 185.00
Change: -5.00 (-2.74%)
Spread: 15.00 (8.824%)
Open: 182.50
High: 182.50
Low: 177.50
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors / PDMRs' Interests in Shares

26 Mar 2024 07:00

RNS Number : 2436I
Synectics PLC
26 March 2024
 

 

 

 

 

 

 

 

 

26 March 2024

 

 

Synectics plc

("Synectics" or the "Company")

 

Directors / PDMRs' Interests in Shares

 

Synectics plc (AIM: SNX), a leader in advanced security and surveillance systems, announces that it has made an award of options ("Options") over, in aggregate, 140,000 ordinary shares of 20p each in the Company ("Ordinary Shares") under its existing Performance Share Plan ("PSP"), to certain Directors and Persons Discharging Managerial Responsibility ("PDMRs"), under its existing Performance Share Plan ("PSP"), as detailed below:

 

Name

Position

Status

Number of Options

Paul Webb

Chief Executive Officer

Executive Director

60,000

Amanda Larnder

Chief Financial Officer

Executive Director

40,000

David Aindow

Business Strategy Director

PDMR

20,000

David Gavin

Divisional Director

PDMR

20,000

 

Following these purchases, the above Directors' and PDMRs' interests in the Ordinary Shares are as follows:

 

Name

Number of Ordinary Shares held

Interest in Ordinary Shares in share schemes

Resultant total interest

% of issued share capital

Paul Webb

57,115

515,079

632,194

3.55

Amanda Larnder

4,326

164,000

168,326

0.95

David Aindow

2,000

80,000

82,000

0.46

David Gavin

0

80,782

80,782

0.45

 

Under the PSP, selected employees are entitled to exercise an option to receive a certain number of Ordinary Shares at any time after a three-year vesting period, exercisable at nil cost. The number of Ordinary Shares that are awarded at the end of the three-year period is dependent on the achievement of certain performance criteria and must be exercised within ten years of the date of award.

 

Vesting of the PSP award is measured according to the average of the Compound Annual Growth Rate ("CAGR") of the Total Shareholder Return Index and the CAGR of Adjusted Underlying Diluted Earnings Per Share. If this average is 20% or more, 100% of the award will vest. If this average is above 10% and below 20%, between 0% and 100% of the award will vest on a straight-line basis. If the average is 10% or less, 0% of the award will vest.

 

Any entitlement under the PSP will lapse on cessation of employment prior to the end of the three-year vesting period, unless cessation of employment is by reason of redundancy, ill health or death.

 

Should the performance criteria be met in full or in part for the Options, it is intended that the appropriate number of Options will be satisfied firstly from any unallocated Ordinary Shares already held within the Company's employee benefit trust with the balance to be satisfied from a new issue of Ordinary Shares.

 

Full details of the PSP were set out in the Company's Annual Report for the year ended 30 November 2023, copies of which are available on the Company's website, www.synecticsplc.com.

 

For further information, please contact:

 

Synectics plc

Paul Webb, Chief Executive Officer

Amanda Larnder, Chief Financial Officer

Claire Stewart, Company Secretary

email: info@synecticsplc.com

Tel: +44 (0) 114 280 2828

www.synecticsplc.com

 

 

Shore Capital

Tel: +44 (0) 20 7408 4090

Tom Griffiths / David Coaten / Rachel Goldstein

 

Vigo Consulting  

Jeremy Garcia / Fiona Hetherington / Aisling Fitzgerald 

synectics@vigoconsulting.com  

Tel: +44 (0) 20 7390 0230  

 

 

 

About Synectics plc

 

Synectics (AIM: SNX) is a leader in advanced security and surveillance systems that help protect people, property, communities, and assets around the world.

 

The Company's expertise is in providing solutions for specific markets where security and surveillance are critical to operations. These include gaming, oil and gas, public space, transport, and critical infrastructure.

 

Synectics has deep industry experience in these markets and works closely with customers to deliver solutions that are tailored to meet their needs. Technical excellence, combined with decades of experience and long-standing customer relationships, provides fundamental differentiation from mainstream suppliers and makes the Company a stand-out in its field.

 

Find out more at www.synecticsplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUNRRRSWUOURR
Date   Source Headline
14th Jul 20207:00 amRNSInterim Results
25th Jun 20209:12 amRNSHolding(s) in Company
16th Jun 20207:00 amRNSMajor Contract Win and Notice of Interim Results
22nd May 20207:00 amRNSContract Wins with Long Term Customers
23rd Apr 202011:49 amRNSResult of AGM
23rd Apr 20207:00 amRNSBusiness Update
6th Apr 202012:24 pmRNSRevised Arrangements for Annual General Meeting
2nd Apr 20209:11 amRNSDirector/PDMR Shareholding
23rd Mar 20202:28 pmRNSBusiness Update: COVID-19
23rd Mar 20201:48 pmRNSAvailability of Report and Accounts and AGM
11th Mar 20204:23 pmRNSDirector/PDMR Shareholding
11th Mar 202012:11 pmRNSHolding(s) in Company
6th Mar 20201:59 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSSettlement of Legal Claim
25th Feb 20207:00 amRNSFinal Results
11th Feb 20204:12 pmRNSHolding(s) in Company
7th Feb 20202:33 pmRNSHolding(s) in Company
7th Feb 202010:43 amRNSReplacement - Holding(s) in Company
7th Feb 20207:00 amRNSNotification of Final Results
6th Feb 20204:58 pmRNSHolding(s) in Company
30th Jan 202012:17 pmRNSReplacement - Holding(s) in Company
28th Jan 20208:58 amRNSHolding(s) in Company
23rd Jan 20209:55 amRNSDirectorate Changes
13th Dec 201912:00 pmRNSDirectorate Change
21st Nov 20198:42 amRNSChange of Registered Office
5th Nov 20198:51 amRNSHolding(s) in Company
30th Oct 201911:06 amRNSSecond Price Monitoring Extn
30th Oct 201911:00 amRNSPrice Monitoring Extension
30th Oct 20197:00 amRNSTrading Update
2nd Oct 20194:12 pmRNSDirector/PDMR Shareholding
23rd Jul 20198:31 amRNSContract Win
23rd Jul 20197:00 amRNSHalf-year Report
21st Jun 20198:16 amRNSNotification of Interim Results
17th Jun 20199:53 amRNSHolding(s) in Company
13th Jun 20198:36 amRNSChange of Adviser
4th Jun 20191:41 pmRNSHolding(s) in Company
23rd May 201912:45 pmRNSDirector/PDMR Shareholding
25th Apr 20197:40 amRNSAGM Statement
24th Apr 20191:00 pmRNSDirector/PDMR Shareholding
27th Mar 20198:32 amRNSExercise of Options and Director/PDMR dealings
26th Mar 20197:00 amRNSContract Win in Gaming Sector
25th Mar 201910:01 amRNSDirectorate Change
21st Mar 201912:09 pmRNSAnnual Report and AGM
21st Mar 20197:00 amRNSOil & Gas Contract Win
8th Mar 20193:59 pmRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFinal Results
25th Feb 20193:17 pmRNSHolding(s) in Company
19th Feb 20193:48 pmRNSDirectorate Update
29th Jan 20197:00 amRNSNotification of Final Results
29th Nov 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.